ABSTRACT
ABSTRACT: Conventional therapies for CD8 + cutaneous T-cell lymphoma include topical steroids, topical nitrogen mustard, topical bexarotene, ultraviolet B therapy, psoralen and ultraviolet A therapy, local radiotherapy, and interferon alfa; however, these treatments are often found to be ineffective. Presented is a case of CD8 + cutaneous T-cell lymphoma with near-complete response to narrow-band ultraviolet therapy because of chronic radiation dermatitis initially believed to be possible progression of a CD8 + cutaneous epidermotropic cytotoxic T-cell lymphoma.
Subject(s)
Antineoplastic Agents , Dermatitis , Lymphoma, T-Cell, Cutaneous , Skin Neoplasms , Ultraviolet Therapy , Humans , Lymphoma, T-Cell, Cutaneous/pathology , Skin Neoplasms/pathology , Antineoplastic Agents/therapeutic use , Ultraviolet Therapy/adverse effects , CD8-Positive T-Lymphocytes/pathology , Dermatitis/pathologyABSTRACT
Sarcomatoid renal cell carcinoma (sRCC) is an aggressive variant of renal cell carcinoma (RCC) that has a significantly lower overall survival. Even after prompt surgical extirpation, this histologic variant progresses rapidly. We present a case of an early recurrence and rapid progression of sRCC despite successful radical resection.
